CION Cancer Clinics
Autoimmune hepatitis and liver cancer risk: what you need to know | CION Cancer Clinics
Autoimmune hepatitis raises the risk of liver cancer mainly when it has scarred the liver into cirrhosis. Without cirrhosis, and with the inflammation well controlled, the risk is low. This page explains where the risk comes from, who needs regular cancer scans, what the words on your report mean, and why staying on treatment is the most useful thing you can do. At CION Cancer Clinics, our specialists help you understand your own risk and plan regular liver checks that fit it.
On this page
- Does autoimmune hepatitis cause liver cancer?
- Which people with autoimmune hepatitis need to think about cancer?
- How is someone with autoimmune hepatitis checked for cancer?
- What do the words on an autoimmune hepatitis report mean?
- What do families get wrong about autoimmune hepatitis?
- What this page cannot tell you
- Common questions about autoimmune hepatitis and cancer
The short answer
Does autoimmune hepatitis cause liver cancer?
Autoimmune hepatitis can raise the risk of liver cancer, but mostly in people whose liver has already scarred into cirrhosis. Without cirrhosis the risk is low, and good control of the inflammation is the main thing that keeps it that way.
What autoimmune hepatitis is
In autoimmune hepatitis the body's own defence system attacks the liver by mistake. It is not caused by a virus, by alcohol or by anything the person did. It can start at any age, in men and women, though it is found more often in women. Many people feel tired or notice yellow eyes. Some feel nothing and are found only because a routine blood test showed raised liver enzymes.
Where the cancer risk comes from
Years of uncontrolled inflammation can leave scar tissue behind. When the scarring becomes widespread, it is called cirrhosis. A cirrhotic liver is constantly repairing itself, and every round of repair carries a small chance of a cell going wrong. That is the pathway to hepatocellular carcinoma (HCC), the most common primary liver cancer. It is the same pathway described on our page on how cirrhosis leads to cancer.
This page is about cancer that starts in the liver. If a scan has found a spot that spread from somewhere else, read primary versus secondary liver cancer first.What moves the risk
Which people with autoimmune hepatitis need to think about cancer?
The diagnosis alone tells you little. What matters is how much scarring the liver carries and how well the disease is controlled.
Cirrhosis is present
This is the group that matters most. Once cirrhosis has formed, the liver is watched for cancer for life, even when the autoimmune hepatitis itself is quiet on treatment.
Inflammation keeps flaring
Repeated flares, stopping medicines early, or a diagnosis made late all give scarring more time to build. Steady control slows or halts that process.
A second liver problem on top
Fatty liver, regular drinking, or hepatitis B or C in the same liver add their own damage. Risks stack rather than replace each other.
Worth telling your doctor about
- Any alcohol, even occasional
- Weight gain or diabetes
- A past hepatitis B or C test result
No cirrhosis, well controlled
This is where most treated people sit. Cancer is uncommon here. The focus is on staying on treatment and checking that scarring is not quietly progressing.
Not sure whether this applies to you?
Ask an oncologistWatching the liver
How is someone with autoimmune hepatitis checked for cancer?
Find out how scarred the liver is
Your hepatologist uses blood tests, an ultrasound and often a stiffness scan called elastography (FibroScan) to judge scarring. Sometimes a biopsy is needed. CION arranges these through partner hepatologists and diagnostic centres.
If there is cirrhosis, start regular scans
People with cirrhosis are usually offered an ultrasound every six months, often with a blood test called AFP (alpha-fetoprotein). Our page on the six-monthly ultrasound explains why.
Keep the autoimmune treatment going
Surveillance does not replace treatment. Controlling the inflammation is what protects the liver from further scarring.
Act on anything new
If an ultrasound shows a new spot, a CT or MRI with contrast usually follows. A spot on a cirrhotic liver is often not cancer, but it always needs that next scan.
Bring in an oncologist if cancer is found
The CION tumour board then plans treatment around both the tumour and how well the liver is working.
On your report
What do the words on an autoimmune hepatitis report mean?
- ALT and AST
- Liver enzymes. They rise when liver cells are inflamed and fall when treatment is working.
- IgG
- A type of antibody in the blood. It is often high in autoimmune hepatitis and is used to track control.
- ANA, ASMA, anti-LKM
- Autoantibodies, meaning antibodies aimed at the body's own tissue. They help make the diagnosis. Their level does not measure cancer risk.
- Fibrosis
- Scarring in the liver. Reports often grade it from mild to severe.
- Cirrhosis
- Widespread scarring that has changed the liver's structure. This is the stage that brings regular cancer checks.
- Remission
- The inflammation is controlled and blood tests are back near normal. It does not mean the treatment can be stopped without advice.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families get wrong about autoimmune hepatitis?
Autoimmune hepatitis is not an infection. It cannot pass to a spouse, a child or anyone sharing a kitchen. Family members do not need to be kept apart.
Medicines such as prednisolone and azathioprine have side effects your doctor will watch for, including some skin cancers with long use. For the liver, though, uncontrolled inflammation is the bigger danger. Stopping treatment on your own is riskier than continuing it.
Normal tests usually mean the treatment is working. Many people relapse after stopping. Any change to the dose is a decision for your hepatologist.
Herbal liver tonics and detox products can injure the liver, and a scarred liver has less room to recover. Tell your doctor about anything you take, without worrying about being judged.
Being straight with you
What this page cannot tell you
It cannot tell you whether you have cirrhosis, or how high your own cancer risk is. That depends on your scans, your blood tests and how your disease has behaved over time. A hepatologist who knows your history is the person to answer it.
Who this does not apply to
If your liver was inflamed by a medicine, a virus or alcohol, this page is not about you. If you are having cancer immunotherapy and your liver tests have risen, that is a different problem, covered on immune hepatitis from immunotherapy. And if you already have liver cancer alongside autoimmune hepatitis, treatment choices depend on the tumour and on liver function, which the tumour board weighs together.
When the evidence is thin
Autoimmune hepatitis is uncommon, so studies of its cancer risk are small. Doctors largely apply what is known about cirrhosis in general. That is a sensible approach, but it means nobody can give you a precise figure.
If you have autoimmune hepatitis with cirrhosis and no one has mentioned regular scans, ask about them at your next visit.Questions we are asked
Common questions about autoimmune hepatitis and cancer
Is autoimmune hepatitis a type of cancer?
No. It is an inflammatory disease in which the immune system attacks the liver. It is not cancer and does not turn into cancer directly. The risk comes later, and mainly if long-term inflammation scars the liver into cirrhosis. Treating it well is how you lower that risk.
I have no cirrhosis. Do I need cancer scans?
Usually not for cancer alone. Your hepatologist will still check your liver regularly to make sure scarring is not building quietly. If a later test shows cirrhosis has developed, regular ultrasound scans would then be added. Ask at each review whether your scarring stage has changed.
Can autoimmune hepatitis be controlled?
Yes. Most people respond well to treatment, and many reach remission, where blood tests return close to normal. Some need to stay on a low level of medicine for a long time. Good control protects the liver and is the most important thing you can do to keep cancer risk low.
Will my children get autoimmune hepatitis?
It is not passed down in a simple way, and most children of a parent with autoimmune hepatitis never develop it. Some families do carry a general tendency towards autoimmune conditions. If a child develops tiredness, yellow eyes or abnormal liver tests, mention the family history to their doctor.
Does it also raise the risk of bile duct cancer?
Autoimmune hepatitis on its own is mainly linked with HCC, the common liver cancer. Some people also have a bile duct condition called primary sclerosing cholangitis, which carries its own bile duct cancer risk. If your doctor has mentioned an overlap syndrome, ask which checks that adds for you.
Can I have immunotherapy for another cancer?
Possibly, but it needs careful thought. Immunotherapy works by stirring up the immune system, and that can cause an autoimmune condition to flare. Your oncologist and hepatologist will weigh the benefit against that risk together, and watch your liver tests closely if treatment goes ahead.
Is it safe to have a baby with autoimmune hepatitis?
Many women with well-controlled autoimmune hepatitis have healthy pregnancies. Planning ahead matters, because some medicines need review before conception and flares can happen after delivery. Talk to your hepatologist before you try, not after a positive test.
Who should I see if I am worried?
Your hepatologist manages the autoimmune hepatitis itself. If a scan has shown a spot on the liver, or you want a second opinion on cancer risk, call the CION helpline. A CION oncologist can review your reports and arrange any further scans through partner centres.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NIDDK — Autoimmune Hepatitis - NIDDK
- MedlinePlus — Autoimmune hepatitis
- American Cancer Society — Liver Cancer Risk Factors
- NHS — Cirrhosis
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Have autoimmune hepatitis and a spot on your scan?
Send us your scans and blood reports and a CION oncologist will explain what they show and what should happen next. One helpline serves every CION centre.